Progress on the pathological tissue microenvironment barrier-modulated nanomedicine

H Han, L Xing, BT Chen, Y Liu, TJ Zhou, Y Wang… - Advanced Drug Delivery …, 2023 - Elsevier
Imbalance in the tissue microenvironment is the main obstacle to drug delivery and
distribution in the human body. Before penetrating the pathological tissue microenvironment …

Breast Cancer: Extracellular Matrix and Microbiome Interactions

L Herrera-Quintana, H Vázquez-Lorente… - International Journal of …, 2024 - mdpi.com
Breast cancer represents the most prevalent form of cancer and the leading cause of cancer-
related mortality among females worldwide. It has been reported that several risk factors …

Bacteria colonization in tumor microenvironment creates a favorable niche for immunogenic chemotherapy

SK Lim, WC Lin, SW Huang, YC Pan… - EMBO Molecular …, 2024 - embopress.org
The tumor microenvironment (TME) presents differential selective pressure (DSP) that favors
the growth of cancer cells, and monovalent therapy is often inadequate in reversing the …

Bacteria-based cancer therapy: Looking forward

MV Tieu, DT Pham, S Cho - Biochimica et Biophysica Acta (BBA)-Reviews …, 2024 - Elsevier
The field of bacteria-based cancer therapy, which focuses on the key role played by the
prevalence of bacteria, specifically in tumors, in controlling potential targets for cancer …

Engineered bacteria breach tumor physical barriers to enhance radio-immunotherapy

Y Zhang, Y Liu, T Li, X Yang, S Lang, P Pei… - Journal of Controlled …, 2024 - Elsevier
Radiotherapy widely applied for local tumor therapy in clinic has been recently reinvigorated
by the discovery that radiotherapy could activate systematic antitumor immune response …

Efficient PEGylated Dendrimer Nanoplatform for Codelivery of Hyaluronidase and Methotrexate: A New Frontier in Chemotherapeutic Efficacy and Tumor Penetration

A Soozanipour, F Ejeian, A Razmjou… - ACS Applied Nano …, 2024 - ACS Publications
The condensed extracellular matrix (ECM) surrounding cancer cells results in the formation
of a biophysical barrier versus chemotherapeutic drug penetration into deeper regions of …

Overcoming the nutritional immunity by engineering iron-scavenging bacteria for cancer therapy

SW Huang, SK Lim, YA Yu, YC Pan, WJ Lien, CY Mou… - Elife, 2024 - elifesciences.org
Certain bacteria demonstrate the ability to target and colonize the tumor microenvironment,
a characteristic that positions them as innovative carriers for delivering various therapeutic …

Coating Dormant Collagenase‐Producing Bacteria with Metal‐Anesthetic Networks for Precision Tumor Therapy

Q Han, F Yang, M Chen, M Zhang, L Wang… - Advanced …, 2024 - Wiley Online Library
Tumor malignancy highly depends on the stiffness of tumor matrix, which mainly consists of
collagen. Despite the destruction of tumor matrix is conducive to tumor therapy, it causes the …

Nanomaterial combined engineered bacteria for intelligent tumor immunotherapy

S Qin, G He, J Yang - Journal of Materials Chemistry B, 2024 - pubs.rsc.org
Cancer remains the leading cause of human death worldwide. Compared to traditional
therapies, tumor immunotherapy has received a lot of attention and research focus due to its …

The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics

J Qian, X Zhang, B Wei, Z Tang, B Zhang - Biochimica et Biophysica Acta …, 2023 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is one of the lethal cancers in the world and its 5-
year survival rate is< 10%. Due to the unique TME and dense tissue structure, its curative …